Omada Adds Cholesterol Care to Its Integrated Platform, Addressing the Silent Driver of Cardiovascular Risk
MWN-AI** Summary
Omada Health (Nasdaq: OMDA) has announced the integration of dedicated cholesterol management into its virtual-first healthcare platform, expanding its focus on comprehensive cardiometabolic care that also encompasses weight, glucose, and blood pressure management. This launch aims to address a significant health gap: a staggering 70% of adults with obesity have elevated cholesterol levels, and many patients with atherosclerotic cardiovascular disease fail to achieve optimal LDL-C levels. Traditional healthcare often inadequately addresses this issue through episodic visits rather than ongoing support.
Dr. Thomas Tsang, Chief Medical Officer of Omada Health, emphasized the necessity of daily behavioral support to effectively manage cholesterol, linking it to reducing overall cardiovascular risks, including the likelihood of heart attacks and strokes. The new initiative focuses on behavior change, medication adherence, and holistic engagement in lifestyle adjustments—positioning high cholesterol within the broader context of individual health rather than treating it in isolation.
Omada's platform employs an innovative care model that utilizes human-led coaching and artificial intelligence to facilitate continuous, personalized care. Multidisciplinary teams, including health coaches and cardiometabolic experts, collaborate to provide resources that aim to improve nutrition, physical activity, and medication compliance, helping patients achieve their cholesterol targets.
Sean Duffy, CEO and Co-Founder of Omada Health, highlighted the demand for consistent cholesterol care in response to evolving healthcare needs, allowing the company to quickly add this service to their established platform. The service is poised to empower members to prevent cardiovascular diseases through proactive health management rather than reactive care after significant health events occur.
With over one million members served, Omada Health continues its mission to redefine chronic care delivery by fostering ongoing support for chronic conditions, aiming for a healthier population overall.
MWN-AI** Analysis
Omada Health’s recent announcement to integrate cholesterol management into its virtual healthcare platform represents a significant step in the evolving landscape of chronic disease management. This strategic move addresses a critical gap in cardiovascular care, particularly for the millions of Americans suffering from obesity and high cholesterol. Importantly, Omada's multifaceted approach combines human-led coaching with AI, allowing personalized, continuous support that goes beyond traditional episodic care.
From an investment perspective, Omada's expansion into cholesterol management signals a robust growth opportunity within the digital health space. The link between high cholesterol and cardiovascular risk cannot be overstated, as evidenced by the statistic that only 41% of adults with atherosclerotic cardiovascular disease achieved optimal LDL-C levels. As demand for comprehensive and accessible healthcare solutions surges, Omada's platform positions itself favorably among employers seeking to enhance their health offerings.
The clinical efficacy demonstrated in Omada's prior lifestyle programs further strengthens its business case. With an engaged user base exceeding one million members, consistent outcomes relating to cardiometabolic risk factors could lead to increased adoption by health plans and employers. This is particularly vital as organizations aim to mitigate healthcare costs associated with chronic disease complications, such as heart attacks and strokes.
Investors should monitor Omada’s ability to execute this integrated model effectively. Ongoing success will hinge on user engagement and demonstrating measurable health outcomes that justify the value proposition to employers and health systems. Given the evolving landscape of digital health and the increasing recognition of the importance of addressing cardiovascular health, Omada Health is well-positioned for growth as it continues to innovate in the management of chronic conditions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider, today announced the expansion of its integrated platform to include dedicated cholesterol management alongside weight, glucose, blood pressure, and GLP-1 support. Up to 70% of adults with obesity have high cholesterol,1 yet among U.S. adults with atherosclerotic cardiovascular disease, only 41% ever reached a healthy LDL-C level (<70 mg/dL).2 This gap underscores a core challenge in traditional care models that are not designed to sustain the day-to-day behaviors required to improve cholesterol numbers over time.
“High cholesterol rarely exists in isolation1,3,4 and is a primary driver of cumulative cardiovascular risk,5 yet it is often managed episodically or without sustained support,1” said Thomas Tsang, MD, MPH, Chief Medical Officer at Omada Health. “When we help members improve their cholesterol through behavior change and medication adherence, we’re not just improving lipid levels; we’re meaningfully lowering cumulative cardiovascular risk and the likelihood of costly, acute events like heart attacks and strokes.6,7 Evidence from Omada’s lifestyle change programs has already shown that virtual, behavior-first interventions can improve multiple cardiometabolic risk factors, including cholesterol, underscoring the importance of adding dedicated cholesterol support to our care model.8”
High cholesterol is a core driver of cardiovascular risk5, yet standard care still manages it through periodic labs and brief visits1 rather than day?to?day support. Omada for Cholesterol is built on Omada’s compassionate intelligence model of human-led coaching amplified by AI to address cholesterol as part of the same interconnected cardiometabolic system as weight, blood pressure, and diabetes, instead of another siloed benefit. Multidisciplinary care teams, including health coaches and cardiometabolic specialists, connect nutrition, activity, behavior change support, and medication adherence guidance to help members’ reach their cholesterol goals.
“Launching with a market-leading employer is a signal that there is a need for between-visit cholesterol care that properly addresses long-term cardiovascular risk in their populations,” said Sean Duffy, CEO & Co?Founder of Omada Health. “Because of our flexible infrastructure, we were able to quickly add cholesterol support on our existing platform, giving customers one partner for integrated cardiometabolic care in response to their demand.”
Omada for Cholesterol is designed to complement primary and specialty care by addressing how cardiovascular risk builds over time, not just how it’s measured in visits. By keeping members engaged in day-to-day behavior change across nutrition, activity, and medication adherence, Omada helps bend the curve of cardiovascular disease, rather than reacting only after acute events occur.
About Omada Health
Omada Health (Nasdaq: OMDA) is on a mission to fix what’s broken in chronic care. Today's healthcare system poorly serves chronic conditions that require ongoing support between doctor visits, like obesity, diabetes, hypertension, and musculoskeletal disorders. Omada’s virtual-first model combines human-led care teams, connected devices, and AI-enabled technology to deliver personalized care at scale, including support for GLP-1 therapy. Omada has served more than one million members since launch across 2,000+ employers, health plans, and health systems. Learn more at omadahealth.com.
Contacts
Rose Ramseth
press@omadahealth.com
Citations
- Lim Y, Haq N, Boster J. Obesity and comorbid conditions. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2024. Available at: https://www.ncbi.nlm.nih.gov/books/NBK574535/.
- MacDougall DE, Ferdinand K, Baum SJ, et al. Cholesterol management in US adults with ASCVD in the Family Heart Database during 2022–23: Current state of care and opportunities for improvement. Am J Prev Cardiol. 2025;24:101354. doi:10.1016/j.ajpc.2025.101354.
- American Heart Association. Know your risk factors for high blood pressure. Available at: https://www.heart.org/en/health-topics/high-blood-pressure/know-your-risk-factors-for-high-blood-pressure. Accessed February 12, 2026.
- Centers for Disease Control and Prevention. Prevalence of self-reported high cholesterol in adults with diabetes, aged 18 years or older, United States, 2021. Behavioral Risk Factor Surveillance System. Available at: https://nccd.cdc.gov/Toolkit/DiabetesBurden/SelfReported/Hc. Accessed February 12, 2026.
- American Heart Association. Prevention and treatment of high cholesterol (hyperlipidemia). Available at: https://www.heart.org/en/health-topics/cholesterol/prevention-and-treatment-of-high-cholesterol-hyperlipidemia. Accessed February 12, 2026.
- American Heart Association. Lifestyle changes to prevent a heart attack. Available at: https://www.heart.org/en/health-topics/heart-attack/life-after-a-heart-attack/lifestyle-changes-for-heart-attack-prevention. Accessed February 12, 2026.
- Palaniappan LP, Allen NB, Almarzooq ZI, et al. 2026 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2026;[Epub ahead of print].
- Castro Sweet CM, Chiguluri V, Gumpina R, et al. Outcomes of a Digital Health Program With Human Coaching for Diabetes Risk Reduction in a Medicare Population. J Aging Health. 2018;30(5):692-710. doi:10.1177/0898264316688791
FAQ**
How does Omada Health Inc. OMDA plan to measure the impact of its dedicated cholesterol management program on long-term cardiovascular risk among its members?
What specific strategies will Omada Health Inc. OMDA implement to ensure medication adherence and behavior change in cholesterol management?
As Omada Health Inc. OMDA expands its platform, what partnerships or collaborations are being pursued to enhance the multidisciplinary care teams involved in cholesterol management?
How does Omada Health Inc. OMDA's virtual-first model compare to traditional care models in addressing the complexities of cardiometabolic health, particularly in regards to cholesterol management?
**MWN-AI FAQ is based on asking OpenAI questions about Omada Health Inc. (NASDAQ: OMDA).
NASDAQ: OMDA
OMDA Trading
-1.47% G/L:
$13.37 Last:
752,809 Volume:
$13.50 Open:
